Kevin M. Charlton - 29 Oct 2021 Form 4/A - Amendment Insider Report for NewHold Investment Corp. II

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
02 Nov 2021, 20:17:15 UTC
Original report date
27 Oct 2021
Prior SEC filing
27 Oct 2021
Next SEC filing
16 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kevin Charlton

Key filing fact

Kevin M. Charlton filed Form 4/A - Amendment for NewHold Investment Corp. II on 02 Nov 2021.

Key facts

  • This page summarizes Kevin M. Charlton's Form 4/A - Amendment filing for NewHold Investment Corp. II.
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Nov 2021, 20:17.

Change

  • Previous filing in this sequence was filed on 27 Oct 2021.
  • Current net transaction value: +$391,578.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHIC transaction Derivative

Warrants to purchase Class A Common Stock

Purchase

Transaction value
$391,578
Shares
+391,578
Change %
+6.9%
Price
$1.00*
Shares after
6,070,254
Date
29 Oct 2021
Ownership
See Footnote
Underlying class
Class A Common Stock
Underlying amount
391,578
Exercise price
$11.50
Footnotes
F1, F2, F3, F4
NHIC transaction Derivative

Class B Common Stock

Other

Transaction value
$0
Shares
-145,640
Change %
-6.6%
Price
$0.000000
Shares after
2,052,374
Date
29 Oct 2021
Ownership
See Footnote
Underlying class
Class A Common Stock
Underlying amount
145,640
Exercise price
Footnotes
F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

In connection with the exercise of the underwriters' over-allotment option, NewHold Industrial Technology Holdings LLC II, the sponsor of the registrant (the "Sponsor"), purchased an additional 391,578 warrants as contemplated under the purchase agreement for the warrants.

Footnote F2

The warrants become exercisable on the later of (i) 30 days after the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.

Footnote F3

The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the registrant's prospectus filed with the SEC.

Footnote F4

The securities reported herein are directly held by the Sponsor, which is controlled by NewHold Enterprises LLC. Investment and voting decisions for NewHold Enterprises LLC are made by Kevin Charlton, Charles Goldman, Charlie Baynes-Reid and Adam Deutsch. The reporting person disclaims any pecuniary interest in the securities reported herein except to the extent of his beneficial interest in NewHold Enterprises LLC.

Footnote F5

As described in the registrant's registration statement on Form S-1 (File No. 333-254667) under the heading "Description of Securities - Founder Shares," the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the registrant's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date.

Footnote F6

As contemplated in connection with the registrant's initial public offering, 145,640 shares of Class B common stock were returned by the Sponsor to the registrant for no consideration and cancelled because the underwriters' over-allotment option was partially exercised and the remaining portion of the option will not be exercised by the underwriters.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .